4Twenteezs with Pablo Zuanic

Speakers:

Michael DeGiglio, President & CEO, Village Farms International

Discussion Points:

· VFF US plans following S3 rescheduling

· Options to enter the Texas medical cannabis market

· VFF participation in the CMS CBD pilot program

· Canadian capacity expansion

· Update on the Dutch operations and 4x capacity increase

· Plans to forward integrate overseas (downstream investments)

· Domestic rec performance and portfolio gaps (if any)

#Villagefarms #VFF #cannabisstocks #cannabisindustry #MSOS #pablozuanic #280e #rescheduling

Speaker:

Charlie Bachtell, CEO & Director, Cresco Labs

Discussion Points:

· A reminder of why rescheduling is so relevant

· Unpacking the DOJ’s General Order of 4/23

· Why the 6/29 hearing is necessary to reach the Final Order stage

· Cresco’s exposure to med and rec

· Treasury/IRS guidance on 280e

· Implications of registering with the DEA at the federal level

· FDA oversight vs. state med regulators

· Path to custody, banking services, uplisting

#crescolabs #charliebachtell #cannabisstocks #cannabisindustry #MSOS #pablozuanic #280e #rescheduling

Speakers:

Pablo Zuanic, Managing Partner, Zuanic & Associates

Anthony Coniglio, CEO, NewLake Capital Partners

Discussion Points: Pablo and Anthony will discuss the 4Q earnings season and sector outlook for the MSO group.

· Recap of 4Q MSOs performance across key metrics

· Benchmarking MSOs B/S and CF

· CY26 sector and company outlook

· Upside from regulatory unlocks (federal/state)

· Potential for M&A

· International angle if applicable

#MRMD #PLTH #VEXT #JUSHF #VREOF #CNTMF #CURAF #GTBIF #VRNO #TCNNF $NLCP #cannabisindustry #Cannabisstocks #pablozuanic #zuanicassociates

Renowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain firsthand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.

Follow us on http://zuanicassociates.com

[email protected] in

X https://x.com/420Odysseus

https://www.linkedin.com/company/zuanic-associates-llc

Disclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.

Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.

This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:

Sascha Mielcarek, CEO, Canify AG

Luke Van der Nest, Commercial Director, MG Health Ltd

Discussion Points:

• description of the deal details
• rationale and expectations
• proforma financials
• brief description about both companies, and track records
• projections for the German MMJ market (and rest of Europe)
• what gaps would be left to fill (with future M&A) for the new company

#Canify #MGHealth #Merger #EuropeanCannabis #GermanyCannabis #Pharma #TLRY #ACB #CGC #CRON #VFF #DBCC #ROMJF #Cannabisindustry #PabloZuanic

Renowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain firsthand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.

Follow us on http://zuanicassociates.com

[email protected] in

X https://x.com/420Odysseus

https://www.linkedin.com/company/zuanic-associates-llc

Disclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.

Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.

This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:

Benjamin Sze, CEO

Stuart Boucher, CFO

Discussion Points:

• International growth outlook and plans
• Benefits from AgMedica integration
• Canadian supply chain
• Performance of infused pre-rolls
• Trends in vape segment
• Cash flow trends and balance sheet

#cannabisstocks #cannabisindustry #DecibelCannabis #DB #DBCCF

Renowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain firsthand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.

Follow us on http://zuanicassociates.com

[email protected] in

X https://x.com/420Odysseus

https://www.linkedin.com/company/zuanic-associates-llc

Disclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.

Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.

This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:

Jared Stanley, Co-Founder & Board Member, Charlotte’s Web

Joseph Dowling, CEO, CV Sciences

John Harloe, General Counsel, Village Farms International (CBDistillery)

Discussion Points:

· Reconciling the CR (11/12) and 12/18 Oval Office announcements (EO signing)

· On the various “emerging” hemp-related bills (Griffiths, etc)

· Will the CR be amended with various “carve-outs” (for non-intoxicating CBD? HDD9 bevs? etc)

· Or will implementation (CR) be delayed (as with the Farm Bill?)

· On the CMMS pilot program giving seniors access to CBD

· Companies (speaking here) plans for 2026

· FDA producing list of various cannabinoids (per CR mandate?)

· Note: To watch the signing of the Executive Order: https://www.youtube.com/watch?v=DTVbPs1RoKo

Speakers:

Daniel Neville, Chief Executive Officer & Partner

Robyn Tannenbaum, Chief Investment Officer & President

Discussion Points:

• Company outlook post the conversion to BDC
• Diversification plans away from cannabis
• Room to fund loan book growth
• Likely book size and metrics by YE26
• Outlook for the mortgage REIT and BDC sector, in general

• Cannabis sector federal and state outlook
• State of the book’s non-accruals
• Managing interest rate risk and unscheduled early repayments

#cannabisstocks #cannabisindustry #AdvanceFlowerCapital #AFCGamma #AFCG

Renowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain firsthand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.

Follow us on http://zuanicassociates.com

[email protected] in

X https://x.com/420Odysseus

https://www.linkedin.com/company/zuanic-associates-llc

Disclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.

Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.

This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:

Anthony Coniglio, Chief Executive Officer, NewLake Capital Partners

Discussion Points

· How potential regulatory changes at the federal (s3) and state (TX, VA, etc) level are impacting demand for credit so far from cannabis (MJ) companies

· Sizing up the competition (other sale leaseback; mortgage REITS; BDCs; regional banks)

· Has sale lease back lost its edge vs. other credit alternatives vs. 5 years ago

· Potential opportunities to fund expansion in Europe

· Quality of the NLCP tenant book, and benchmarking with IIPR

· A discussion of all key tenants, and any problem areas

· Ability to cover the dividend

· NLCP diversifying outside cannabis

· Potential catalysts for NLCP shares

#cannabisstocks #cannabisindustry #NewLakeCapital #REIT #NLCP

Renowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain firsthand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.

Follow us on http://zuanicassociates.com

[email protected] in

X https://x.com/420Odysseus

https://www.linkedin.com/company/zuanic-associates-llc

Disclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.

Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.

This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:

Alex Rabinovich, Chairman and CEO, Intercure Ltd

Mike Gorenstein, Chairman and CEO, Cronos Group

Discussion Points:

• The Cronos and Intercure operations in Israel
• State of the domestic market
• Impact of reforms implemented in 2024
• Key producers, importers, distributors, and retailers
• How the market was impacted by Oct 7
• Israel’s export potential
• The country’s presumed advantage in genetics
• How Israel can better leverage its pioneering MJ know-how globally

#cannabisstocks #cannabisdispensary #globalcannabis #Israelcannabis #cannabislegalization #Intercure #Cronosgroup

Renowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain firsthand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.

Follow us on http://zuanicassociates.com

[email protected] in

X https://x.com/420Odysseus

https://www.linkedin.com/company/zuanic-associates-llc

Disclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.

Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.

This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.

Speakers:

Sascha Mielcarek, CEO, Canify AG

Constantin von der Groeben, Co-Founder and Strategic Advisor, Demecan

Philip Schetter, CEO, Cantourage Group SE

Discussion Points:

• A look back at 2025: market growth; pricing; segmentation

• How imports and the supply chain are evolving

• Will the Bundestag modify the MOH proposal

• How companies will adapt to the potential changes

• Is there more financing available for the German companies

• M&A and consolidation outlook?

• Plans outside Germany

#cannabisstocks #cannabisdispensary #globalcannabis #germanycannabis #cannabislegalization #canify #DEMECAN #Cantourage

Renowned analyst Pablo Zuanic conducts insightful interviews with key figures in the cannabis industry, helping investors better understand the dynamic sectoral landscape and gain first hand knowledge of the various operators. Zuanic & Associates is a boutique equity research, consulting, and advisory firm covering the emerging consumer sectors. Led by renowned Wall Street analyst Pablo Zuanic, the firm covers companies in North America and overseas, publishing both thematic and stock-specific research. The firm’s publications are often covered by the business wires, trade publications, and social media.

Follow us on http://zuanicassociates.com

[email protected] in

X https://x.com/420Odysseus

https://www.linkedin.com/company/zuanic-associates-llc

Disclaimer: The content presented in this video clip is an integral part of Zuanic & Associates’ due diligence and research process. The views and opinions expressed by the speakers are solely their own and do not necessarily represent the views or opinions of Zuanic & Associates, its affiliates, or its employees.

Zuanic & Associates may have current or future business relationships with the companies or individuals mentioned in this video; however, any such relationships are not intended to influence the content presented herein. This video is provided solely for educational and informational purposes.

This video is not intended as investment advice, nor should it be construed as a recommendation to engage in any investment activity. Investors are encouraged to conduct their own thorough research and analysis and to seek advice from qualified financial advisors before making any investment decisions. The information contained in this video should be used as a supplementary tool, not as the sole basis for any investment decision.